Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prexasertib and Irinotecan in DSRCT and RMS
NCT04095221Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2019
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prexasertib in desmoplastic small round cell tumor (DSRCT), rhabdomyosarcoma (RMS), sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 2019; status: completed.
02
Drugs
prexasertib
03
Conditions
desmoplastic small round cell tumor (DSRCT)rhabdomyosarcoma (RMS)
Beyond the preview
Go deeper on NCT04095221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04095221.